A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
Bell
B A
BA
D000818:Animals; D001323:Autoantibodies / Q000097:blood / Q000276:immunology*; D002675:Child, Preschool; D003888:Desensitization, Immunologic; D005169:Factor VIII / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications* / Q000276:immunology / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D008297:Male; D008403:Mass Screening; D006472:Oral Hemorrhage / Q000209:etiology / Q000628:therapy*; D013552:Swine / Q000276:immunology
D001323:Autoantibodies; D005169:Factor VIII